Target
Fatty acid-binding protein, adipocyte
Ligand
BDBM212447
Substrate
n/a
Meas. Tech.
Time Resolved-Fluorescence Energy Transfer (TR-FRET) Assay
pH
7.5±n/a
Temperature
298.15±n/a K
IC50
150±n/a nM
Comments
extracted
Citation
 Buettelmann, BCeccarelli, SMConte, AKuehne, HKuhn, BNeidhart, WObst Sander, URichter, H Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors US Patent  US9278918 Publication Date 3/8/2016 
Target
Name:
Fatty acid-binding protein, adipocyte
Synonyms:
A-FABP | AFABP | ALBP | Adipocyte lipid-binding protein | FABP4 | FABP4_HUMAN | Fatty acid binding protein adipocyte | Fatty acid-binding protein 4 | Fatty acid-binding protein 4 (FABP4)
Type:
Enzyme
Mol. Mass.:
14719.23
Organism:
Homo sapiens (Human)
Description:
P15090
Residue:
132
Sequence:
MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA
  
Inhibitor
Name:
BDBM212447
Synonyms:
US9278918, 33
Type:
Small organic molecule
Emp. Form.:
C19H19ClN2O3
Mol. Mass.:
358.819
SMILES:
OC(=O)C1(CCCC1)NC(=O)Nc1cc(Cl)ccc1-c1ccccc1
Structure:
Search PDB for entries with ligand similarity: